World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: German Clinical Trials Register
Last refreshed on: 8 April 2024
Main ID:  DRKS00012426
Date of registration: 09/05/2017
Prospective Registration: Yes
Primary sponsor: DGOM e.V. c/o Consalta
Public title: Clinical-practical validity of vegetative rhythms in peripheral physiological signals
Scientific title: Clinical-practical validity of vegetative rhythms in peripheral physiological signals
Date of first enrolment: 01/10/2020
Target sample size: 200
Recruitment status: Recruiting
URL:  http://drks.de/search/en/trial/DRKS00012426
Study type:  interventional
Study design:  Allocation: Randomized controlled study; Masking: Blinded (masking used); Control: No treatment / Standard of care; Assignment: parallel; Study design purpose: basic science  
Phase:  N/A
Countries of recruitment
Germany Switzerland
Contacts
Name: Holger    Pelz
Address:  Gothestr. 18 68161 Mannheim Germany
Telephone: +491712856374
Email: praxis@dr-holger-pelz.de
Affiliation:  DGOM e.V. c/o Consalta
Name: Holger    Pelz
Address:  Gothestr. 18 68161 Mannheim Germany
Telephone: +491712856374
Email: praxis@dr-holger-pelz.de
Affiliation:  DGOM e.V. c/o Consalta
Key inclusion & exclusion criteria
Inclusion criteria: Somatoform, psychosomatic and functional disorders and pain syndromes
Exclusion criteria: Absence of consent, minority, non-working persons, morphine medication, psychotropic medication, basic psychiatric disorders

Age minimum: 18 Years
Age maximum: 70 Years
Gender: All
Health Condition(s) or Problem(s) studied

F45
R52.1
Chronic intractable pain
Somatoform disorders
R52.1
Intervention(s)
Group 1: osteopathic treatment: Vault Hold

osteopathic treatment: CV4

respectively at T0, T1, T2 at one week interval

Group 2: SHAM treatment

respectively at T0, T1, T2 at one week interval
Primary Outcome(s)
Pain at T0, T1, T2
Secondary Outcome(s)
SF12, MAIA 2, STAI 5, ICR-ICD10 Symptom Rating,
change of physiological reactions
T0, T1 (week 1), T2 (week 2)
Secondary ID(s)
Source(s) of Monetary Support
Head-Genuit-Stiftung, HGS
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 03/04/2017
Contact:
ethikkommission@aekn.de
Ethikkommission bei der Ă„rztekammer Niedersachsen, Unterkommission zur Beurteilung medizinischer Forschung am Menschen
+49-511-3802208
ethikkommission@aekn.de
Results
Results available:
Date Posted:
Date Completed:
URL: http://drks.de/search/en/trial/DRKS00012426#studyResults
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history